Are you basically saying that the Signatera is more accurate at diagnosing microscopic residual disease (is the same thing as microscopic cells lingering about which can lead to metastasis?) than the Guardant360 which goes by blood work rather than tissue? I just got Guardant results online (dr out of town) and it didn’t detect any mutations, including KRAS. These type of tests are all new to me so I dint know anything about them yet. Seems like Guardant360 is good for deciding which clinical studies might be appropriate; but I dint know for sure if this is the purpose of the test. Originally, I thought it was to detect those sneaky microscopic cells.